metoclopramide hydrochloride
Capsules, hard liquid
15 mg
Manufacturer usually replies in 32 days
Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Monaco
GMP approvals
EU GMP
Manufacturer #17667
This pharmaceutical company focuses on developing and manufacturing medications primarily for gastrointestinal disorders, oncology/hematology, and respiratory conditions. They offer a range of dosage forms including effervescent suppositories, powders, capsules, and inhalants. Key therapy areas include constipation, vomiting/nausea, chronic lymphocytic leukemia, and infectious diseases. While their primary production lines seem to be prescription medications, they may also produce over-the-counter drugs given their focus on gastrointestinal health. The company operates in regions like the EU and likely North America based on their website's design and language options.